Distinct Mechanisms of Over-Representation of Landmarks and Rewards in the Hippocampus.


Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
07 07 2020
Historique:
received: 03 12 2019
revised: 06 04 2020
accepted: 16 06 2020
entrez: 9 7 2020
pubmed: 9 7 2020
medline: 29 4 2021
Statut: ppublish

Résumé

In the hippocampus, locations associated with salient features are represented by a disproportionately large number of neurons, but the cellular and molecular mechanisms underlying this over-representation remain elusive. Using longitudinal calcium imaging in mice learning to navigate in virtual reality, we find that the over-representation of reward and landmark locations are mediated by persistent and separable subsets of neurons, with distinct time courses of emergence and differing underlying molecular mechanisms. Strikingly, we find that in mice lacking Shank2, an autism spectrum disorder (ASD)-linked gene encoding an excitatory postsynaptic scaffold protein, the learning-induced over-representation of landmarks was absent whereas the over-representation of rewards was substantially increased, as was goal-directed behavior. These findings demonstrate that multiple hippocampal coding processes for unique types of salient features are distinguished by a Shank2-dependent mechanism and suggest that abnormally distorted hippocampal salience mapping may underlie cognitive and behavioral abnormalities in a subset of ASDs.

Identifiants

pubmed: 32640229
pii: S2211-1247(20)30845-7
doi: 10.1016/j.celrep.2020.107864
pmc: PMC7434948
mid: NIHMS1610245
pii:
doi:

Substances chimiques

Nerve Tissue Proteins 0
Shank2 protein, mouse 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

107864

Subventions

Organisme : NIDA NIH HHS
ID : R01 DA017310
Pays : United States

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Interests Y.H. was supported in part by Takeda Pharmaceutical and DWANGO.

Références

Neuron. 2018 Jan 3;97(1):83-91.e5
pubmed: 29249287
Proc Natl Acad Sci U S A. 1997 Aug 5;94(16):8918-21
pubmed: 9238078
Learn Mem. 2012 Feb 15;19(3):84-90
pubmed: 22345484
Front Psychol. 2015 Jan 23;6:31
pubmed: 25667579
Front Mol Neurosci. 2018 Jun 19;11:107
pubmed: 29970986
Neuron. 2016 Jan 20;89(2):285-99
pubmed: 26774160
PLoS One. 2015 May 06;10(5):e0125354
pubmed: 25946002
J Neurosci. 2004 Sep 1;24(35):7681-9
pubmed: 15342735
Nat Neurosci. 2010 Aug;13(8):995-1002
pubmed: 20639874
Exp Brain Res. 1978 Apr 14;31(4):573-90
pubmed: 658182
Neuron. 2000 Oct;28(1):41-51
pubmed: 11086982
Neuron. 2018 Jul 11;99(1):179-193.e7
pubmed: 30008297
Exp Neurol. 1978 Nov;62(2):282-97
pubmed: 729680
Neuron. 2009 Sep 24;63(6):747-60
pubmed: 19778505
Neuron. 2016 Aug 3;91(3):652-65
pubmed: 27397517
J Neurosci. 1996 Jan 15;16(2):823-35
pubmed: 8551362
Elife. 2019 Mar 01;8:
pubmed: 30822270
Arch Clin Neuropsychol. 2017 Jun 1;32(4):472-482
pubmed: 28164221
Nat Neurosci. 2015 Sep;18(9):1281-1290
pubmed: 26214372
Neuron. 2004 Apr 22;42(2):283-95
pubmed: 15091343
eNeuro. 2017 May 2;4(3):
pubmed: 28484738
Behav Neurosci. 1997 Feb;111(1):20-34
pubmed: 9109621
Nature. 2012 Jun 13;486(7402):261-5
pubmed: 22699620
Science. 2016 Jan 8;351(6269):aaa5694
pubmed: 26744409
Curr Biol. 2013 Mar 4;23(5):399-405
pubmed: 23434282
Neuron. 2014 Aug 20;83(4):764-70
pubmed: 25144874
J Neurophysiol. 2010 Dec;104(6):3691-704
pubmed: 20554834
PLoS One. 2012;7(12):e51286
pubmed: 23240011
Nat Neurosci. 2013 Mar;16(3):264-6
pubmed: 23396101
JCI Insight. 2017 Oct 19;2(20):
pubmed: 29046483
J Neurosci. 2009 Aug 5;29(31):9918-29
pubmed: 19657042
PLoS Biol. 2009 Aug;7(8):e1000173
pubmed: 19688032
Nat Neurosci. 2017 Nov;20(11):1612-1623
pubmed: 28869582
Neuron. 2014 Jun 4;82(5):1129-44
pubmed: 24836505
Neurobiol Learn Mem. 2016 Nov;135:146-151
pubmed: 27400866
J Neurosci. 2008 Oct 8;28(41):10278-86
pubmed: 18842887
Hippocampus. 1996;6(6):749-62
pubmed: 9034860
Nat Commun. 2017 Feb 20;8:14531
pubmed: 28218283
Nature. 2002 Mar 7;416(6876):90-4
pubmed: 11882899
Nat Neurosci. 2010 Nov;13(11):1433-40
pubmed: 20890294
Elife. 2019 Jan 17;8:
pubmed: 30652683
Science. 2018 Nov 23;362(6417):945-949
pubmed: 30467169
Neuron. 2005 Oct 20;48(2):345-58
pubmed: 16242413
Hippocampus. 1991 Apr;1(2):193-205
pubmed: 1669293
J Neurosci. 1987 Jul;7(7):1951-68
pubmed: 3612226
J Neurosci. 1989 Aug;9(8):2737-63
pubmed: 2769364
Science. 1993 Aug 20;261(5124):1055-8
pubmed: 8351520
Nat Neurosci. 2011 Aug 07;14(9):1174-81
pubmed: 21822270
Front Behav Neurosci. 2011 Oct 28;5:69
pubmed: 22065409
Nat Neurosci. 2014 Feb;17(2):269-79
pubmed: 24336151
J Neurosci. 2001 Mar 1;21(5):1635-44
pubmed: 11222654
Science. 1998 Jun 26;280(5372):2121-6
pubmed: 9641919
Hippocampus. 1994 Aug;4(4):410-21
pubmed: 7874233
Proc Natl Acad Sci U S A. 2011 Dec 27;108(52):21241-6
pubmed: 22160721
Cell Rep. 2017 Oct 24;21(4):1102-1115
pubmed: 29069591
Proc Natl Acad Sci U S A. 2013 Jan 2;110(1):378-83
pubmed: 23256159
Nat Genet. 2010 Jun;42(6):489-91
pubmed: 20473310

Auteurs

Masaaki Sato (M)

RIKEN Center for Brain Science, Wako, Saitama 351-0198, Japan; PRESTO, Japan Science and Technology Agency, Kawaguchi, Saitama 332-0012, Japan; Graduate School of Science and Engineering, Saitama University, Saitama 338-8570, Japan; Brain and Body System Science Institute, Saitama University, Saitama 338-8570, Japan; RIKEN Brain Science Institute, Wako, Saitama 351-0198, Japan. Electronic address: masaaki.sato@riken.jp.

Kotaro Mizuta (K)

RIKEN Brain Science Institute, Wako, Saitama 351-0198, Japan; Department of Pharmacology, Kyoto University Graduate School of Medicine, Kyoto 606-8501, Japan.

Tanvir Islam (T)

RIKEN Center for Brain Science, Wako, Saitama 351-0198, Japan; RIKEN Brain Science Institute, Wako, Saitama 351-0198, Japan.

Masako Kawano (M)

RIKEN Brain Science Institute, Wako, Saitama 351-0198, Japan.

Yukiko Sekine (Y)

RIKEN Center for Brain Science, Wako, Saitama 351-0198, Japan; RIKEN Brain Science Institute, Wako, Saitama 351-0198, Japan.

Takashi Takekawa (T)

RIKEN Brain Science Institute, Wako, Saitama 351-0198, Japan; Faculty of Informatics, Kogakuin University, Tokyo 163-8677, Japan.

Daniel Gomez-Dominguez (D)

RIKEN Brain Science Institute, Wako, Saitama 351-0198, Japan; Instituto Cajal, CSIC, Madrid 28002, Spain.

Alexander Schmidt (A)

Department of Pharmacology, Kyoto University Graduate School of Medicine, Kyoto 606-8501, Japan; Max Planck Institute for Dynamics and Self-Organization, Göttingen 37077, Germany; Max Planck Institute for Experimental Medicine, Göttingen 37075, Germany; Campus Institute for Dynamics of Biological Networks, Göttingen 37075, Germany; Center for Biostructural Imaging of Neurodegeneration, Göttingen 37075, Germany.

Fred Wolf (F)

Max Planck Institute for Dynamics and Self-Organization, Göttingen 37077, Germany; Max Planck Institute for Experimental Medicine, Göttingen 37075, Germany; Campus Institute for Dynamics of Biological Networks, Göttingen 37075, Germany; Center for Biostructural Imaging of Neurodegeneration, Göttingen 37075, Germany.

Karam Kim (K)

RIKEN Brain Science Institute, Wako, Saitama 351-0198, Japan.

Hiroshi Yamakawa (H)

RIKEN Brain Science Institute, Wako, Saitama 351-0198, Japan; The University of Tokyo, Tokyo 113-8654, Japan; Whole Brain Architecture Initiative, Tokyo 133-0057, Japan; RIKEN Center for Biosystems Dynamics Research, Osaka 565-0874, Japan.

Masamichi Ohkura (M)

Graduate School of Science and Engineering, Saitama University, Saitama 338-8570, Japan; Brain and Body System Science Institute, Saitama University, Saitama 338-8570, Japan.

Min Goo Lee (MG)

National Creative Research Initiative Center for Cell Membrane Transport, Yonsei University College of Medicine, Seoul 120-752, Republic of Korea.

Tomoki Fukai (T)

Okinawa Institute of Science and Technology, Onna, Okinawa, 904-0495, Japan.

Junichi Nakai (J)

Graduate School of Science and Engineering, Saitama University, Saitama 338-8570, Japan; Brain and Body System Science Institute, Saitama University, Saitama 338-8570, Japan.

Yasunori Hayashi (Y)

Brain and Body System Science Institute, Saitama University, Saitama 338-8570, Japan; RIKEN Brain Science Institute, Wako, Saitama 351-0198, Japan; Department of Pharmacology, Kyoto University Graduate School of Medicine, Kyoto 606-8501, Japan. Electronic address: yhayashi-tky@umin.ac.jp.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH